Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(4):242-244; doi:10.1093/jnci/dji068
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Lipscomb, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipscomb, J.
Related Collections
Right arrowRelated Memo to the Media
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

EDITORIAL

Managed Care Market Penetration, Spillover Effects, and the Quality of Cancer Care

Joseph Lipscomb

Correspondence to: Joseph Lipscomb, PhD, Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA 30322 (e-mail: jlipsco@sph.emory.edu).

The first 150 words of the full text of this article appear below.

Proponents of managed care extol its potential to control costs and improve quality through an emphasis on prevention, screening, and treatment that is evidence based, coordinated, and prudent in the use of public and private dollars. The focus is on promoting wellness, a win–win situation from the standpoint of both health outcomes and costs.

Critics counter that managed care organizations—budget constrained and unable to fully capture the potential cost savings from aggressive prevention and screening because of inevitable fluctuations in plan enrollment—actually have substantial incentives to limit access to care. Specifically, managed care organizations seek to control costs by modulating the volume and mix of services through a combination of provider incentives and restraints, limits on investments in technology and infrastructure, and a maze of price and nonprice barriers imposed on enrollees.

The complex truth of the matter surely lies somewhere between these two stylized characterizations. This becomes quickly evident . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Memo to the Media

Press Release: Study Examines Effect of Managed Care on Quality of Care for Cancer Patients
Sarah L. Zielinski
J Natl Cancer Inst 2005 97: 241. [Extract] [Full Text]



This article has been cited by other articles:


Home page
JCOHome page
J. A. Pagan, D. A. Asch, C. J. Brown, C. E. Guerra, and K. Armstrong
Lack of Community Insurance and Mammography Screening Rates Among Insured and Uninsured Women
J. Clin. Oncol., April 10, 2008; 26(11): 1865 - 1870.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
M. V. Pauly and J. A. Pagan
Spillovers And Vulnerability: The Case Of Community Uninsurance
Health Aff., September 1, 2007; 26(5): 1304 - 1314.
[Abstract] [Full Text] [PDF]